Transcatheter Embolization and Occlusion Devices Market Research Report - Global Forecast till 2027

Global Transcatheter Embolization and Occlusion Devices Market Research Report by Product (Coiled Devices and Non-Coiled Devices), Indication (Peripheral Vascular Disease, Oncology, Neurology and Urology), End User (Hospitals, Clinics and Ambulatory Surgery Centers) and Region - Forecast till 2027

ID: MRFR/HC/6392-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2019-2024 to 2020-2027. Cordially fill the sample form for updated data.


Market Scenario


Global Transcatheter Embolization and Occlusion Devices Market is Expected to Register a Healthy CAGR Over the Forecast Period. The market held a market value of USD 3,290.4 million in 2018 and is projected to grow at a CAGR of 9.9% during the forecast period. Transcatheter embolization and occlusion (TEO) is a minimally invasive (MI) procedure performed in interventional radiology wherein a synthetic embolus is placed or inserted through a fine catheter in the blood vessel to obstruct the blood flow towards tumor or specific area of the body. Coils are permanent embolic agents which come in a variety of shapes and sizes and are coated with chemotherapeutic drugs that block the blood supply as well as induce cytotoxicity to attack the tumor. Particulate agents such as polyvinyl alcohol (PVA) and gelatin-impregnated acrylic polymer spheres are suspended in liquid and injected into the bloodstream to block small blood vessels. This procedure is used to prevent abnormal bleeding, eliminate abnormal connections between arteries and veins, and to treat the aneurysm. Few of the major factors driving the market growth are growing burden of targeted diseases, technological advances in the devices with enhanced efficiency, changing shift from clipping to coiling, rising preference for minimally invasive surgeries (MISs), and increasing adoption of TEO devices. Venous malformations are the most common of all vascular anomalies. For instance, according to the International Society for Auricular Reconstruction (ISAR), in 2017, the overall incidence of venous malformations was reported in 1% to 4% of the population, without any predilection in the sex. On the flip side, the high cost of products and the presence of stringent regulatory framework for product commercialization are anticipated to impede the market growth during the forecast period.


Segmentation


The global transcatheter embolization and occlusion devices market has been segmented into product, indication, end user, and region.


 By product, the market has been segmented into coiled devices and non-coiled devices. The coiled devices segment has been further categorized into pushable coils and detachable coils. The non-coiled devices segment has been additionally divided into flow diverting devices, embolization particles, liquid embolic, other embolization and occlusion devices, and accessories.


 The coiled devices segment is expected to dominate the market due to the availability of wide-range of coils in various shapes and sizes that enables suitable product selection for different cases, making coiling a preferred treatment for embolization. The non-coiled devices segment is likely to witness lucrative market growth during the forecast period due to increasing demand for flow diverting devices, embolization particles, liquid embolic, and accessories.


 On the basis of indication, the market has been divided into peripheral vascular disease, oncology, neurology, urology, and others.


 Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.


 The global transcatheter embolization and occlusion devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The transcatheter embolization and occlusion devices market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


 The European transcatheter embolization and occlusion devices market has been segmented into Western Europe and Eastern Europe. Western Europe, transcatheter embolization and occlusion devices market, has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


 The transcatheter embolization and occlusion devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The transcatheter embolization and occlusion devices market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players



  • Medtronic plc

  • Stryker Corporation

  • Terumo Corporation

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Pfizer Inc.

  • Cardinal Health

  • DePuy Synthes

  • Cook Medical

  • Sirtex Medical Limited


Regional Market Summary


Global Transcatheter Embolization and Occlusion Devices Market Share (%), by Region, 2018
 Transcatheter Embolization and Occlusion Devices Market_Image


Source: White Papers, Company Presentations, Annual Reports, and MRFR Analysis


Geographically, the Americas held substantial market share in 2018 attributed to the presence of key market participants, sophisticated healthcare infrastructure and reimbursement coverage, and the incidence of target diseases (fibroid tumor and arteriovenous malformations) in the US and Canada. For instance, as per the data provided by the Association of Neurological Surgeons (AANS), in 2017, the prevalence of arteriovenous malfunctions (AVM) was 18 people per 100,000 population in the US.


Europe would be the second largest value contributor in the global market due to robust growth in radioembolization spheres, drug-eluting beads, and flow-diverting devices. Improved detection and screening have treated hepatocellular carcinoma and metastatic liver cancer population across the country.


Asia-Pacific is expected to represent profitable market growth from 2018 to 2024 owing to the booming medical tourism industry in emerging economies, namely, China, India, Australia, and Malaysia, growing awareness about TEO procedure, and increasing adoption of transcatheter embolization and occlusion procedures. For instance, the International Medical Travel Journal (IMTJ) reported that Indian hospitals served 460,000 international patients from 2015 to 2016 for various surgical procedures.


The transcatheter embolization and occlusion devices market in the Middle East & Africa would witness the modest market growth rate from 2018 to 2024. The Middle East would spearhead the market.
Global Transcatheter Embolization and Occlusion Devices Market, by Product



  • Coiled Devices

    • Pushable Coils

    • Detachable Coils



  • Non-Coiled Devices

    • Flow-Diverting Devices

    • Embolization Particles

    • Liquid Embolic

    • Other Embolization and Occlusion Devices

    • Accessories




Global Transcatheter Embolization and Occlusion Devices Market, by Indication



  • Peripheral Vascular Disease

  • Oncology

  • Neurology

  • Urology

  • Others


Global Transcatheter Embolization and Occlusion Devices Market, by End User



  • Hospitals and Clinics

  • Ambulatory Surgery Centers (ASCs)

  • Others


Global Transcatheter Embolization and Occlusion Devices Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Transcatheter embolization and occlusion devices providers

  • Venture capitalists

  • Medical devices companies

  • Research and academic institutes

  • Healthcare facilities

  • Association and government bodies

  • Market research and consulting service providers

  • Corporate entities



Frequently Asked Questions (FAQ) :


The transcatheter embolization and occlusion devices market is projected to grow at a 9.9% CAGR between 2019-2024.

The Americas is expected to lead the transcatheter embolization and occlusion devices market.

Different end users of the transcatheter embolization and occlusion devices market include ambulatory surgery centers, hospitals and clinics, and others.

Key competitors in the transcatheter embolization and occlusion devices market include Merit Medical Systems, Sirtex Medical Limited, Cook Medical, Cardinal Health, DePuy Synthes, Terumo Corporation, Pfizer Inc., Stryker Corporation, Boston Scientific Corporation, Medtronic plc, and Abbott Laboratories.

Strict regulatory framework and costlier products may limit market growth.

Table of Contents

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6 Global Transcatheter Embolization and Occlusion Devices Market, by Product

6.1 Introduction

6.2 Coiled Devices

6.2.1 Pushable Coils

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2 Detachable Coils

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Non-Coiled Devices

6.3.1 Flow-Diverting Devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2 Embolization Particles

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3 Liquid Embolic

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.4 Other Embolization and Occlusion Devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.5 Accessories

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7 Global Transcatheter Embolization and Occlusion Devices Market, by Indication

7.1 Introduction

7.2 Peripheral Vascular Disease

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Oncology

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Neurology

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Urology

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8 Global Transcatheter Embolization and Occlusion Devices Market, by End User

8.1 Introduction

8.2 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Ambulatory Surgery Centers (ASCs)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9 Global Transcatheter Embolization and Occlusion Devices Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Developments & Strategies

Chapter 11 Company Profiles

11.1 Medtronic plc

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financial Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.1.6 Key Strategies

11.2 Stryker Corporation

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategies

11.3 Boston Scientific Corporation

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.3.6 Key Strategies

11.4 Terumo Corporation

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.4.6 Key Strategies

11.5 Pfizer Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategies

11.6 DePuy Synthes

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.6.6 Key Strategies

11.7 Cardinal Health

11.7.1 Company Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7.6 Key Strategies

11.8 Abbott Laboratories

11.8.1 Company Overview

11.8.2 Product Overview

11.8.3 Financial Overview

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8.6 Key Strategies

11.9 Cook Medical

11.9.1 Company Overview

11.9.2 Product Overview

11.9.3 Financial Overview

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.9.6 Key Strategies

11.10 Sirtex Medical Limited

11.10.1 Company Overview

11.10.2 Product Overview

11.10.3 Financial Overview

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10.6 Key Strategies

11.11 Merit Medical Systems

11.11.1 Company Overview

11.11.2 Product Overview

11.11.3 Financial Overview

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.11.6 Key Strategies

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Transcatheter Embolization and Occlusion Devices Industry

Chapter 13 Appendix

List of Tables

Table 1 Global Transcatheter Embolization and Occlusion Devices Market Synopsis, 2020–2027

Table 2 Global Transcatheter Embolization and Occlusion Devices Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Transcatheter Embolization and Occlusion Devices Market, by Region, 2020–2027 (USD Million)

Table 4 Global Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 5 Global Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 6 Global Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 7 North America: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 8 North America: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 9 North America: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 10 US: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 11 US: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 12 US: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 13 Canada: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 14 Canada: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 15 Canada: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 16 Latin America: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 17 Latin America: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 18 Latin America: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 19 Europe: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 20 Europe: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 21 Europe: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 22 Western Europe: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 23 Western Europe: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 24 Western Europe: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 25 Eastern Europe: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 26 Eastern Europe: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 27 Eastern Europe: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 29 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market, by Product, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market, by End User, 2020–2027 (USD Million)

List of Figures

Figure 1 Research Process

Figure 2 Segmentation for Global Transcatheter Embolization and Occlusion Devices Market

Figure 3 Segmentation Market Dynamics for Global Transcatheter Embolization and Occlusion Devices Market

Figure 4 Global Transcatheter Embolization and Occlusion Devices Market Share, by Product, 2020

Figure 5 Global Transcatheter Embolization and Occlusion Devices Market Share, by Indication, 2020

Figure 6 Global Transcatheter Embolization and Occlusion Devices Market Share, by End User, 2020

Figure 7 Global Transcatheter Embolization and Occlusion Devices Market Share, by Region, 2020

Figure 8 North America: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2020

Figure 9 Europe: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2020

Figure 10 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2020

Figure 11 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2020

Figure 12 Global Transcatheter Embolization and Occlusion Devices Market: Company Share Analysis, 2020 (%)

Figure 13 Medtronic plc: Key Financials

Figure 14 Medtronic plc: Segmental Revenue

Figure 15 Medtronic plc: Geographical Revenue

Figure 16 Stryker Corporation: Key Financials

Figure 17 Stryker Corporation: Segmental Revenue

Figure 18 Stryker Corporation: Geographical Revenue

Figure 19 Boston Scientific Corporation: Key Financials

Figure 20 Boston Scientific Corporation: Segmental Revenue

Figure 21 Boston Scientific Corporation: Geographical Revenue

Figure 22 Terumo Corporation: Key Financials

Figure 23 Terumo Corporation: Segmental Revenue

Figure 24 Terumo Corporation: Geographical Revenue

Figure 25 Pfizer Inc.: Key Financials

Figure 26 Pfizer Inc.: Segmental Revenue

Figure 27 Pfizer Inc.: Geographical Revenue

Figure 28 DePuy Synthes: Key Financials

Figure 29 DePuy Synthes: Segmental Revenue

Figure 30 DePuy Synthes: Geographical Revenue

Figure 31 Cardinal Health: Key Financials

Figure 32 Cardinal Health: Segmental Revenue

Figure 33 Cardinal Health: Geographical Revenue

Figure 34 Abbott Laboratories: Key Financials

Figure 35 Abbott Laboratories: Segmental Revenue

Figure 36 Abbott Laboratories: Geographical Revenue

Figure 37 Cook Medical: Key Financials

Figure 38 Cook Medical: Segmental Revenue

Figure 39 Cook Medical: Geographical Revenue

Figure 40 Sirtex Medical Limited: Key Financials

Figure 41 Sirtex Medical Limited: Segmental Revenue

Figure 42 Sirtex Medical Limited: Geographical Revenue

Figure 43 Merit Medical Systems: Key Financials

Figure 44 Merit Medical Systems: Segmental Revenue

Figure 45 Merit Medical Systems: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.